Neurobiology of Aging
Volume 28, Issue 4 , Pages 533-536 , April 2007

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease

  • Antón Álvarez

      Affiliations

    • EuroEspes Biomedical Research Center, 15166 A Coruña, Spain
    • Corresponding Author InformationCorresponding author at: Department of Neuropharmacology, EuroEspes Biomedical Research Center, Santa Marta de Babío, 15166 Bergondo, A Coruña, Spain. Tel.: +34 981 78 05 05; fax: +34 981 78 05 11.
    • ,
  • Ramón Cacabelos

      Affiliations

    • EuroEspes Biomedical Research Center, 15166 A Coruña, Spain
    • ,
  • Carolina Sanpedro

      Affiliations

    • EuroEspes Biomedical Research Center, 15166 A Coruña, Spain
    • ,
  • Manuel García-Fantini

      Affiliations

    • Servicio de Neurocirugía, Hospital Juan Canalejo, 15006 A Coruña, Spain
    • ,
  • Manuel Aleixandre

      Affiliations

    • Facultad de Psicología, Universidad de Granada, 18071 Granada, Spain

Received 22 November 2005 ,Revised 17 February 2006 ,Accepted 18 February 2006.

References 

  1. Álvarez XA, Franco A, Fernández-Novoa L, Cacabelos R. Blood levels of histamine, IL-1β and TNF-α in patients with mild to moderate Alzheimer disease. Mol Chem Neuropathol. 1996;29:237–252
  2. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, D.C.: American Psychiatric Association; 1994;
  3. Beyer K, Lao JI, Álvarez XA, Cacabelos R. Differential implications of APOE E4 in Alzheimer's disease and vascular dementia in the Spanish population. Alzheimer's Res. 1996;2:215–220
  4. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A: Biol Sci Med Sci. 1999;54(7):357–364
  5. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med. 2002;8(12):1390–1397
  6. Del Villar K, Miller CA. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA. 2004;101:4210–4215
  7. Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, Niikura T, et al. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci USA. 2003;100:13042–13047
  8. Kenchappa P, Yadav A, Singh G, Nandana S, Banerjee K. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. J Neurosci Res. 2004;76(4):466–474
  9. Landin-Wilhelmsen K, Lundberg PA, Lappas G, Wilhelmsen L. Insulin-like growth factor I levels in healthy adults. Horm Res. 2004;62(Suppl. 1):8–16
  10. Li R, Strohmeyer R, Liang Z, Lue LF, Rogers J. CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease. Neurobiol Aging. 2004;25:991–999
  11. Lombardi VRM, García M, Rey L, Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease individuals. J Neuroimmunol. 1999;97:163–171
  12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA Work Group. Neurology. 1984;34:939–944
  13. Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, et al. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia. J Endocrinol Invest. 2001;24:139–146
  14. Mustafa A, Lannfelt L, Lilius L, Islam A, Winblad B, Adem A. Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord. 1999;10(6):446–451
  15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308
  16. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signalling mechanisms in Alzheimer's disease—is this type 3 diabetes?. J Alzheimers Dis. 2005;7:63–80
  17. Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003;74(9):1200–1205
  18. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA. 1999;96(17):9879–9884
  19. Watanabe T, Koba S, Kawamura M, Itokawa M, Idei T, Nakagawa Y, et al. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism. 2004;53(4):476–482
  20. Zhao M, Cribbs DH, Anderson AJ, Cumming BJ, Su JH, Wasserman AJ, et al. The induction of the TNFalpha death domain signalling pathway in Alzheimer's disease brain. Neurochem Res. 2003;28:307–318

PII: S0197-4580(06)00081-9

doi: 10.1016/j.neurobiolaging.2006.02.012

Neurobiology of Aging
Volume 28, Issue 4 , Pages 533-536 , April 2007

Article Tools

* Image Usage & Resolution